As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...
A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...
Young Arthur is just 17 months old and is facing a lengthy stay at Great Ormond Street hospital ...
This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...
Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyltm Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...
Many in Ukraine assume that the alerts are automated. A rare look inside an emergency-response center reveals the specialists ...
Lockheed's Lamprey drone latches onto ship hulls to recharge while delivering autonomous underwater warfare capabilities in a ...
Scientists using the ALMA telescope have created the most-detailed-ever map of the Milky Way's chaotic center. The ...